These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35272714)

  • 1. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.
    Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
    Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
    Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.
    Weir C; Sung-In Jang H; Fernando SL
    Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.
    Jover Cerdá V; Rodríguez Pacheco R; Doménech Witek J; Alonso Hernández S; Durán García R; Real Panisello M; Marco de la Calle FM
    Allergy Asthma Clin Immunol; 2022 May; 18(1):43. PubMed ID: 35624518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis.
    Li DH; Lee E; Song C
    Allergy Asthma Clin Immunol; 2022 Jun; 18(1):57. PubMed ID: 35725661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy.
    Khokhar D; O'Shea KM; Akin C; Baldwin JL; Benjamin MR; Ravikumar R; Hosler M; McMorris MS; Sanders GM; Troost JP; Baptist AP; Oberdoerster DT; Kovalszki A
    J Allergy Clin Immunol Glob; 2022 Nov; 1(4):209-216. PubMed ID: 36090592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines.
    Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
    Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
    J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypopigmentation following intradermal allergy skin testing performed as part of mRNA COVID-19 vaccine allergy evaluation.
    Imameldin A; Ibrahim Y; Ibrahim T; Mobayed H
    Qatar Med J; 2022; 2022(2):9. PubMed ID: 35909405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination.
    Lim XR; Tan JWL; Chan GYL; Hou J; Xie L; Goh VHL; Boon J; Lee SSM; Teo CM; Tan SC; Leong KP; Thong BYH; Leung BPL
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
    Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm.
    Pesqué D; Pujol RM; Marcantonio O; Vidal-Navarro A; Ramada JM; Arderiu-Formentí A; Albalat-Torres A; Serra C; Giménez-Arnau AM
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Allergy? Skin Testing and Challenge at a Tertiary Pediatric Hospital in Melbourne, Australia.
    Cheung A; Choo S; Perrett KP
    J Allergy Clin Immunol Pract; 2019; 7(5):1541-1549. PubMed ID: 30682574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation.
    Trautmann A; Brockow K; Behle V; Stoevesandt J
    J Allergy Clin Immunol Pract; 2019; 7(7):2218-2224. PubMed ID: 30980898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study.
    Kayode OS; Nakonechna A; Siew LQC; Dziadzio M; Kennard L; Rutkowski K; Mirakian R; Wagner A
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):93-100.e4. PubMed ID: 38561050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
    Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
    J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
    Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
    Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.